| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |